http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02191217-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_931a8dde993231d359680cd7213e00be
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
filingDate 1989-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a43241566cc62cc08700b83e2be2a21
publicationDate 1990-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02191217-A
titleOfInvention Medicine for tissue damage containing inositol triphosphate
abstract PURPOSE: To obtain a medicine for preventing, alleviating and treating damage of tissue, comprising inositol triphosphate. n CONSTITUTION: This medicine is obtained by including at least one kind of isomer of inositol triphosphate (IP 3 ), mixing the isomer with a pharmaceutically active compound such as steroids, a gold compound, a penicillamine, an antimalarial agent or an immunosuppressive agent and preparing the mixture. The medicine can be prepared in the form of tablets, granules or solution and contains 0.01-1.5g IP 3 per unit dose. The medicine is useful for tissue damage concerning formation of edema and leakage of blood vessel and also useful for tissue damage concerning burn, rhinitis, asthma, etc. Preferred IP 3 includes D-myoinositol-1,2,6-triphosphate. n COPYRIGHT: (C)1990,JPO
priorityDate 1988-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6310727-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226502261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57473858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226502262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14389199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12068910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226501542

Total number of triples: 49.